BL Pharmtech Corp. (KOSDAQ: 065170)

Market Cap	19.13B
Revenue (ttm)	16.71B
Net Income (ttm)	3.20B
Shares Out	88.97M
EPS (ttm)	35.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,353,660
Open	218.00
Previous Close	213.00
Day's Range	209.00 - 238.00
52-Week Range	204.00 - 672.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About BL Pharmtech

BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd. BL Pharmtech Corp. was founded in 1995 and is headquartered in Yongin, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 15
• Stock Exchange: KOSDAQ
• Ticker Symbol: 065170

Financial Performance

In 2023, BL Pharmtech's revenue was 24.53 billion, an increase of 8.89% compared to the previous year's 22.52 billion. Losses were -148.85 million, -98.93% less than in 2022.